Acarix CADScor® | Coronary Artery Disease Risk Assessment | MediHeart Medical Center Güzelyurt
Acarix CADScor® is an AI-supported, non-invasive acoustic diagnostic technology that helps evaluate the probability of coronary artery disease. How is the CADScor® test performed, who is it recommended for, and in what situations is it used? Get detailed information through the evaluations of Prof. Dr. Osman Beton.
Acarix CADScor®
In the evaluation of patients with chest pain, shortness of breath, or suspected coronary artery disease, reaching an accurate diagnosis in the shortest possible time is of great importance. However, not every chest pain originates from cardiovascular occlusion, nor does every patient directly require advanced imaging methods or interventional procedures. For this reason, next-generation diagnostic technologies that can help reduce unnecessary advanced tests in appropriate patients are used in the field of cardiology today. Acarix CADScor® is an AI-supported and non-invasive acoustic analysis system developed to help evaluate the probability of coronary artery disease.
CADScor® technology analyzes low-frequency sounds generated during cardiac operation using high-precision sensors. AI algorithms evaluate the obtained acoustic data alongside the patient’s age, gender, and clinical characteristics, contributing to risk analysis regarding coronary artery disease. Radiation is not used during the procedure, catheters are not inserted into veins, and contrast media is not administered. Therefore, the test can be used as one of the supportive diagnostic methods in the initial evaluation phase for the appropriate patient group.
At MediHeart Medical Center Güzelyurt Cardiology Department, Acarix CADScor® evaluations are interpreted by our Cardiology Specialist Prof. Dr. Osman Beton together with the patient’s complaints, physical examination findings, ECG, Echocardiography, and other cardiological examinations. The goal is to evaluate the probability of coronary artery disease more comprehensively and determine the most appropriate diagnostic approach for each patient.
What is Acarix CADScor®?
Acarix CADScor® is an AI-supported acoustic analysis technology that helps evaluate the probability of coronary artery disease (Coronary Artery Disease – CAD).
During the test, micro-sounds generated by the heart are recorded via a sensitive sensor placed on the chest wall. The AI-supported analysis system evaluates these sounds to provide information that supports the clinical decision-making process regarding the probability of coronary artery disease.
CADScor® is not a standalone diagnostic method. Results must be evaluated by a cardiology specialist together with other clinical findings.
In Which Cases Can Acarix CADScor® Be Used?
CADScor® can particularly be used in evaluating appropriate patients with low and intermediate probability regarding coronary artery disease.
The main areas of use are as follows:
Evaluation of chest pain
Suspected coronary artery disease
Chest discomfort developing with exertion
Initial evaluation regarding coronary artery disease
Patient groups where it can contribute to reducing unnecessary advanced tests
Clinical situations deemed appropriate by the cardiology specialist
The suitability of the test is evaluated individually for each patient.
Is Preparation Required Before Acarix CADScor®?
Special preparation is usually not required before the CADScor® test.
It is sufficient for the patient to inform the cardiology specialist about current medications, existing heart conditions, and complaints. As the procedure is completed in a short time, it does not affect daily life.
How is Acarix CADScor® Applied?
During the test, the patient lies in a supine resting position. A special sensor is placed on the chest area, and low-frequency sounds generated by the heart are recorded for a few minutes.
The obtained acoustic data are analyzed by the AI-supported CADScor® algorithm. The score obtained as a result of the analysis is interpreted together with the patient’s age, gender, clinical findings, and other cardiological evaluations.
Radiation is not used during the procedure, vascular access is not performed, and contrast media is not administered. After the test is completed, the patient can return to daily life immediately.
What Are the Advantages of Acarix CADScor® Technology?
Acarix CADScor® is one of the next-generation diagnostic technologies developed to help evaluate the probability of coronary artery disease. Thanks to its AI-supported acoustic analysis system, it can evaluate micro-sounds generated by the heart and contribute to the clinical decision-making process. However, CADScor® is not a standalone diagnostic test, and results must be interpreted by a cardiology specialist together with other examinations.
In appropriate patients, Acarix CADScor®:
Can contribute to the evaluation of the probability of coronary artery disease.
Can be applied without using radiation.
Does not require inserting catheters into veins.
Can be performed without using contrast media.
Is a non-invasive examination method completed in a short time.
Can support the cardiology specialist’s planning for advanced tests.
Can contribute to reducing unnecessary advanced imaging methods in the appropriate patient group.
The CADScor® result is not used to make a definitive diagnosis or treatment decision on its own. It should be addressed as part of the clinical evaluation process.
Which Diseases Can Acarix CADScor® Contribute to Evaluating?
CADScor® is a technology specifically developed for evaluating the probability of coronary artery disease.
The main evaluation areas are as follows:
Coronary artery disease (Coronary Artery Disease – CAD)
Suspected stenosis in vessels feeding the heart
Evaluation of whether chest pain is of cardiac origin
Initial evaluation process in low and intermediate-risk group patients
Support for cardiovascular risk analysis
When deemed necessary, CADScor® results are evaluated together with ECG, Echocardiography, Stress Test, Coronary CT Angiography, Coronary Angiography, and other advanced cardiological examinations.
Process After CADScor®
After the test is completed, the obtained results are evaluated in detail by the cardiology specialist. The CADScor® score does not provide a definitive diagnosis on its own and must be interpreted together with the patient’s complaints, physical examination, ECG findings, and other cardiological examinations.
According to the results obtained, advanced imaging methods can be planned, current treatment can be reviewed, or regular cardiological follow-up can be recommended. While no additional examination is required for some patients, advanced diagnostic methods such as Coronary CT Angiography or Coronary Angiography may be necessary for others.
Importance of Expert Experience in Acarix CADScor® Evaluation
Although AI-supported analysis systems can offer important information, correct interpretation of this data is possible through the clinical evaluation of a cardiology specialist. Making a decision based solely on the CADScor® result without considering the patient’s risk factors, complaints, family history, physical examination, and other test results together is not appropriate.
At MediHeart Medical Center Güzelyurt Cardiology Department, Prof. Dr. Osman Beton examines CADScor® analysis results together with all cardiological evaluations of the patient to create a personalized diagnostic and treatment plan.
Frequently Asked Questions
Is Acarix CADScor® a painful procedure?
No. The test is completely painless. Heart sounds are recorded via a sensor placed on the chest wall.
Is radiation used during CADScor®?
No. Radiation is not used in the CADScor® test. The procedure is not an ultrasound, tomography, or X-ray method.
Does CADScor® replace coronary angiography?
No. CADScor® is a supportive diagnostic method that helps evaluate the probability of coronary artery disease. When deemed necessary, coronary angiography or other advanced examinations can still be planned.
How long does the test take?
The procedure is usually completed within a few minutes, including preparation time, and the patient can return to daily life immediately.
Can CADScor® be applied to everyone?
No. The suitability of the test is determined in accordance with the patient’s age, complaints, risk factors, and the clinical evaluation of the cardiology specialist.
Conclusion
Acarix CADScor® is an AI-supported, non-invasive acoustic analysis technology that helps evaluate the probability of coronary artery disease. Being radiation-free, not requiring contrast media, and being applicable in a short time allows it to make significant contributions to cardiology evaluation in the appropriate patient group. However, CADScor® is not a standalone diagnostic method, and its results must be interpreted together with a detailed cardiological evaluation.
In line with the comprehensive evaluations performed by Prof. Dr. Osman Beton at MediHeart Medical Center Güzelyurt Cardiology Department, Acarix CADScor® results are analyzed on a personalized basis, and necessary advanced test or treatment plans are created. Patients applying from across Güzelyurt, TRNC, Cyprus, and North Cyprus can obtain detailed information about Acarix CADScor®, coronary artery disease, chest pain, cardiology evaluation, cardiovascular diseases, and interventional cardiology services. If you have chest pain, discomfort developing with exertion, or risk factors regarding coronary artery disease, early cardiology evaluation can help establish an accurate diagnosis and appropriate treatment plan.